Advanced search
Publication Cover
Future Medicinal Chemistry Latest Articles
Submit an article Journal homepage
13
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Quinazoline sulfonamide derivatives targeting MicroRNA-34a/MDM4/p53 apoptotic axis with radiosensitizing activity

Aiten M Soliman1 Drug Radiation Research Department, National Center for Radiation Research & Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo 11787, EgyptORCID Iconhttps://orcid.org/0000-0001-6562-9828
ORCID Icon,
Ahmad S Kodous2 Radiation Biology Department, National Center for Radiation Research & Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo 11787, EgyptCorrespondence[email protected]
,
Diana A Al-Sherif3 Technology of Radiology and Medical Imaging, Faculty of Applied Medical Sciences, 6th of October University, Giza 12585, Egypt.
&
Mostafa M Ghorab1 Drug Radiation Research Department, National Center for Radiation Research & Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo 11787, EgyptCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4250-0452
ORCID Icon
Received 19 Nov 2023, Accepted 15 Mar 2024, Published online: 25 Apr 2024

References

  • Dara S, Dhamercherla S, Jadav SS, Babu CM, Ahsan MJ. Machine learning in drug discovery: a review. Artif. Intell. Rev. 55(3), 1947–1999 (2022).
  • Offringa R, Kötzner L, Huck B, Urbahns K. The expanding role for small molecules in immuno-oncology. Nat. Rev. Drug Disc. 21, 821–840 (2022).
  • Sun J, Xu M, Ru J et al. Small molecule-mediated targeting of microRNAs for drug discovery: experiments, computational techniques, and disease implications. Eur. J. Med. Chem. 275, 115500 (2023).
  • Warner KD, Hajdin CE, Weeks KM. Principles for targeting RNA with drug-like small molecules. Nat. Rev. Drug Discov. 17(8), 547–558 (2018).
  • Janga SC, Tzakos A. Structure and organization of drug-target networks: insights from genomic approaches for drug discovery. Mol. Biosyst. 5(12), 1536–1548 (2009).
  • Guan L, Disney MD. Recent advances in developing small molecules targeting RNA. ACS Chem. Biol. 7(1), 73–86 (2012).
  • Ying S-Y, Chang DC, Lin S-L. The microRNA (miRNA): overview of the RNA genes that modulate gene function. Mol. Biotechnol. 38, 257–268 (2008).
  • Cooper G, Adams K. The Cell: a Molecular Approach. Oxford University Press (2023).
  • Yoo BK, Santhekadur PK, Gredler R et al. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma. Hepatology 53(5), 1538–1548 (2011).
  • Feng J, Hu S, Liu K, Sun G, Zhang Y. The role of microRNA in the regulation of tumor epithelial–mesenchymal transition. Cells 11(13), 1981 (2022).
  • Pan W, Chai B, Li L, Lu Z, Ma Z. p53/microRNA-34 axis in cancer and beyond. Heliyon 9, e15155 (2023).
  • Rokavec M, Li H, Jiang L, Hermeking H. The p53/miR-34 axis in development and disease. J. Mol. Cell Biol. 6(3), 214–230 (2014).
  • Ito Y, Inoue A, Seers T et al. Identification of targets of tumor suppressor microRNA-34a using a reporter library system. Proc. Natl Acad. Sci. USA 114(15), 3927–3932 (2017).
  • Itahana K, Dimri G, Campisi J. Regulation of cellular senescence by p53. Eur. J. Biochem. 268(10), 2784–2791 (2001).
  • Shay JW, Roninson IB. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23(16), 2919–2933 (2004).
  • Tarasov V, Jung P, Verdoodt B et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6(13), 1586–1593 (2007).
  • Bommer GT, Gerin I, Feng Y et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 17(15), 1298–1307 (2007).
  • Okada N, Lin C-P, Ribeiro MC et al. A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. Genes Dev. 28(5), 438–450 (2014).
  • Mandke P, Wyatt N, Fraser J, Bates B, Berberich SJ, Markey MP. MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame. PLOS ONE 7(8), e42034 (2012).
  • Markey M, Berberich SJ. Full-length hdmX transcripts decrease following genotoxic stress. Oncogene 27(52), 6657–6666 (2008).
  • Navarro F, Lieberman J. miR-34 and p53: new insights into a complex functional relationship. PLOS ONE 10(7), e0132767 (2015).
  • Wade M, Li Y-C, Wahl GM. MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nat. Rev. Cancer 13(2), 83–96 (2013).
  • Bautista-Sánchez D, Arriaga-Canon C, Pedroza-Torres A et al. The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics. Mol. Ther. Nucleic Acids 20, 409–420 (2020).
  • Alotaibi AG, Li JV, Gooderham NJ. Tumour necrosis factor-alpha (TNF-α)-induced metastatic phenotype in colorectal cancer epithelial cells: mechanistic support for the role of microRNA-21. Cancers (Basel) 15(3), 627 (2023).
  • He Q, Ye A, Ye W et al. Cancer-secreted exosomal miR-21-5p induces angiogenesis and vascular permeability by targeting KRIT1. Cell Death Dis. 12(6), 576 (2021).
  • Escobar T, Yu C-R, Muljo SA, Egwuagu CE. STAT3 activates miR-155 in Th17 cells and acts in concert to promote experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 54(6), 4017–4025 (2013).
  • Luo F, Xu Y, Ling M et al. Arsenite evokes IL-6 secretion, autocrine regulation of STAT3 signaling, and miR-21 expression, processes involved in the EMT and malignant transformation of human bronchial epithelial cells. Toxicol. Appl. Pharmacol. 273(1), 27–34 (2013).
  • Sun X, Ma X, Wang J et al. Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal. Oncotarget 8(22), 36137 (2017).
  • Liu Y, Luo F, Wang B et al. STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells. Cancer Lett. 370(1), 125–135 (2016).
  • Niu G, Wright KL, Huang M et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21(13), 2000–2008 (2002).
  • Zeng L, He X, Wang Y et al. MicroRNA-210 overexpression induces angiogenesis and neurogenesis in the normal adult mouse brain. Gene Ther. 21(1), 37–43 (2014).
  • Ge X-T, Lei P, Wang H-C et al. miR-21 improves the neurological outcome after traumatic brain injury in rats. Sci. Rep. 4(1), 1–11 (2014).
  • Soliman AM, Karam HM, Mekkawy MH, Ghorab MM. Antioxidant activity of novel quinazolinones bearing sulfonamide: potential radiomodulatory effects on liver tissues via NF-κB/PON1 pathway. Eur. J. Med. Chem. 197, 112333 (2020).
  • Soliman AM, Karam HM, Mekkawy MH, Higgins M, Dinkova-Kostova AT, Ghorab MM. Radiomodulatory effect of a non-electrophilic NQO1 inducer identified in a screen of new 6,8-diiodoquinolin-4(3H)-ones carrying a sulfonamide moiety. Eur. J. Med. Chem. 200, 112467 (2020).
  • Soliman AM, Ghorab WM, Lotfy DM, Karam HM, Ghorab MM, Ramadan LA. Novel iodoquinazolinones bearing sulfonamide moiety as potential antioxidants and neuroprotectors. Sci. Rep. 13(1), 15546 (2023).
  • Abbas SE, Awadallah FM, Ibrahin NA, Said EG, Kamel GM. New quinazolinone–pyrimidine hybrids: synthesis, anti-inflammatory, and ulcerogenicity studies. Eur. J. Med. Chem. 53, 141–149 (2012).
  • Zayed MF, Hassan MH. Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents. Saudi Pharm. J. 22(2), 157–162 (2014).
  • Ghorab MM, Alqahtani AS, Soliman AM, Askar AA. Antimicrobial, anticancer and immunomodulatory potential of new quinazolines bearing benzenesulfonamide moiety. Future Med. Chem. 15, 275–290 (2023).
  • Ghorab MM, Alqahtani AS, Soliman AM, Askar AA. Novel N-(substituted) thioacetamide quinazolinone benzenesulfonamides as antimicrobial agents. Int. J. Nanomedicine 15, 3161 (2020).
  • Soliman AM, Ghorab MM. Exploration of N-alkyl-2-[(4-oxo-3-(4-sulfamoylphenyl)-3,4-dihydroquinazolin-2-yl)thio] acetamide derivatives as anticancer and radiosensitizing agents. Bioorg. Chem. 88, 102956 (2019).
  • El-Gazzar MG, Ghorab MM, Amin MA, Korany M, Khedr MA, El-Gazzar MG. Computational, in vitro and radiation-based in vivo studies on acetamide quinazolinone derivatives as new proposed purine nucleoside phosphorylase inhibitors for breast cancer. Eur. J. Med. Chem. 248, 115087 (2023).
  • Soliman AM, Ghorab MM, Bua S, Supuran CT. Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: synthesis, biological evaluation and radiosensitizing activity. Eur. J. Med. Chem. 200, 112449 (2020).
  • Alsaid MS, Al-Mishari AA, Soliman AM, Ragab FA, Ghorab MM. Discovery of benzo [g] quinazolin benzenesulfonamide derivatives as dual EGFR/HER2 inhibitors. Eur. J. Med. Chem. 141, 84–91 (2017).
  • Zahran SS, Ragab FA, El-Gazzar MG, Soliman AM, Mahmoud WR, Ghorab MM. Antiproliferative, antiangiogenic and apoptotic effect of new hybrids of quinazoline-4 (3H)-ones and sulfachloropyridazine. Eur. J. Med. Chem., 245, 114912 (2023).
  • Kashyap M, Das D, Preet R et al. Scaffold hybridization in generation of indenoindolones as anticancer agents that induce apoptosis with cell cycle arrest at G2/M phase. Bioorg. Med. Chem. lett. 22(7), 2474–2479 (2012).
  • Ghorab MM, Ragab FA, Heiba HI, Soliman AM. Design and synthesis of some novel 4-chloro-N-(4-(1-(2-(2-cyanoacetyl) hydrazono) ethyl) phenyl) benzenesulfonamide derivatives as anticancer and radiosensitizing agents. Eur. J. Med. Chem. 117, 8–18 (2016).
  • Ghorab MM, Sa El-Gaby M, Alsaid SM et al. Novel thiourea derivatives bearing sulfonamide moiety as anticancer agents through COX-2 inhibition. Anti Cancer Agents Med. Chem. 17(10), 1411–1425 (2017).
  • Rippin TM, Bykov VJ, Freund S, Selivanova G, Wiman KG, Fersht AR. Characterization of the p53-rescue drug CP-31398 in vitro and in living cells. Oncogene 21(14), 2119–2129 (2002).
  • Furman RR, Sharman JP, Coutre SE et al. Idelalisib and rituximab in relapsed chronic lymphocytic leukemia. N. Engl. J. Med. 370(11), 997–1007 (2014).
  • Șandor A, Ionuț I, Marc G, Oniga I, Eniu D, Oniga O. Structure–activity relationship studies based on quinazoline derivatives as EGFR kinase inhibitors (2017–present). Pharmaceuticals 16(4), 534 (2023).
  • Roskoski R Jr. ErbB/HER protein-tyrosine kinases: structures and small molecule inhibitors. Pharmacol. Res. 87, 42–59 (2014).
  • Das D, Hong J. Recent advancements of 4-aminoquinazoline derivatives as kinase inhibitors and their applications in medicinal chemistry. Eur. J. Med. Chem. 170, 55–72 (2019).
  • Soliman AM, Khalil A, Ramadan E, Ghorab MM. Induction of apoptosis, cytotoxicity and radiosensitization by novel 3,4-dihydroquinazolinone derivatives. Bioorg. Med. Chem. Lett. 49, 128308 (2021).
  • Nowar RM, Osman AEE, Abou-Seri SM, El Moghazy SM, Abou El Ella DA. Design, synthesis and biological evaluation of some novel quinazolinone derivatives as potent apoptotic inducers. Future Med. Chem. 10(10), 1191–1205 (2018).
  • Zhang G-H, Xue W-B, An Y-F et al. Distinct novel quinazolinone exhibits selective inhibition in MGC-803 cancer cells by dictating mutant p53 function. Eur. J. Med. Chem. 95, 377–387 (2015).
  • Lee K, Jeong K-W, Lee Y et al. Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors. Eur. J. Med. Chem. 45(11), 5420–5427 (2010).
  • Machado VA, Peixoto D, Costa R et al. Synthesis, antiangiogenesis evaluation and molecular docking studies of 1-aryl-3-[(thieno[3,2-b] pyridin-7-ylthio)phenyl] ureas: discovery of a new substitution pattern for type II VEGFR-2 Tyr kinase inhibitors. Bioorg. Med. Chem. 23(19), 6497–6509 (2015).
  • Mctigue M, Murray BW, Chen JH, Deng Y-L, Solowiej J, Kania RS. Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors. Proc. Natl Acad. Sci. USA 109, 18281–18289 (2012).
  • Popowicz GM, Czarna A, Wolf S et al. Structures of low molecular weight inhibitors bound to MDMX and MDM2 reveal new approaches for p53–MDMX/MDM2 antagonist drug discovery. Cell Cycle 9(6), 1104–1111 (2010).
  • Duncan DB. Multiple range and multiple F tests. Biometrics 11(1), 1–42 (1955).
  • El Ella DaA, Ghorab MM, Heiba HI, Soliman AM. Synthesis of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety for evaluation as anticancer and radiosensitizing agents. Med. Chem. Res. 21(9), 2395–2407 (2012).
  • Baskar R, Lee KA, Yeo R, Yeoh K-W. Cancer and radiation therapy: current advances and future directions. Int. J. Med. Sci. 9(3), 193 (2012).
  • Garrison WM. Reaction mechanisms in the radiolysis of peptides, polypeptides, and proteins. Chem. Rev. 87(2), 381–398 (1987).
  • Ghorab MM, Abdel-Kader MS, Alqahtani AS, Soliman AM. Synthesis of some quinazolinones inspired from the natural alkaloid L-norephedrine as EGFR inhibitors and radiosensitizers. J. Enzyme Inhib. Med. Chem. 36(1), 218–237 (2021).
  • Ghorab MM, Soliman AM, Bua S, Supuran CT. Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline–sulfonamide conjugates as selective human carbonic anhydrases IX/XII inhibitors. Bioorg. Chem. 107, 104618 (2021).
  • Zahedifard M, Faraj FL, Paydar M et al. Synthesis, characterization and apoptotic activity of quinazolinone Schiff base derivatives toward MCF-7 cells via intrinsic and extrinsic apoptosis pathways. Sci. Rep. 5(1), 1–17 (2015).
  • Soliman AM, Alqahtani AS, Ghorab MM. Novel sulfonamide benzoquinazolinones as dual EGFR/HER2 inhibitors, apoptosis inducers and radiosensitizers. J. Enzyme Inhib. Med. Chem. 34(1), 1030–1040 (2019).
  • Silva JL, Lima CG, Rangel LP et al. Recent synthetic approaches towards small molecule reactivators of p53. Biomolecules 10(4), 635 (2020).
  • Zhu S, Li T, Tan J et al. Bax is essential for death receptor-mediated apoptosis in human colon cancer cells. Cancer Biother. Radiopharm. 27(9), 577–581 (2012).
  • Al-Obeed O, Vaali-Mohammed M-A, Eldehna WM et al. Novel quinazoline-based sulfonamide derivative (3D) induces apoptosis in colorectal cancer by inhibiting JAK2-STAT3 pathway. Onco Targets Ther. 11, 3313–3322 (2018).
  • Ji R, Cheng Y, Yue J et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ. Res. 100(11), 1579–1588 (2007).
  • Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers. Mol. Cancer 6, 1–7 (2007).
  • Yang Q, Diamond MP, Al-Hendy A. The emerging role of extracellular vesicle-derived miRNAs: implication in cancer progression and stem cell related diseases. J. Clin. Epigenet. 2(1), PMID: 27099870 (2016).
  • Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29(6 Suppl. 16), 15–18 (2002).
  • Fischer I, Gagner JP, Law M, Newcomb EW, Zagzag D. Angiogenesis in gliomas: biology and molecular pathophysiology. Brain Pathol. 15(4), 297–310 (2005).
  • Ghorab MM, Alsaid MS, Soliman AM, Ragab FA. VEGFR-2 inhibitors and apoptosis inducers: synthesis and molecular design of new benzo[g] quinazolin bearing benzenesulfonamide moiety. J. Enzyme Inhib. Med. Chem. 32(1), 893–907 (2017).
  • Reuben SC, Gopalan A, Petit DM, Bishayee A. Modulation of angiogenesis by dietary phytoconstituents in the prevention and intervention of breast cancer. Mol. Nutr. Food Res. 56(1), 14–29 (2012).
  • Ferrara N, Kerbel RS. Angiogenesis as a therapeutic target. Nature 438(7070), 967–974 (2005).
  • Li Z, Wang B, Tang L, Chen S, Li J. Quinazoline derivative compound (11d) as a novel angiogenesis inhibitor inhibiting VEGFR2 and blocking VEGFR2-mediated Akt/mTOR/p70s6k signaling pathway. Iran. J. Basic Med. Sci. 19(4), 411 (2016).
  • Hussain A, Qazi AK, Mupparapu N et al. Modulation of glycolysis and lipogenesis by novel PI3K selective molecule represses tumor angiogenesis and decreases colorectal cancer growth. Cancer Lett. 374(2), 250–260 (2016).
  • Hussain A, Qazi AK, Mupparapu N et al. A novel PI3K axis selective molecule exhibits potent tumor inhibition in colorectal carcinogenesis. Mol. Carcinog. 55(12), 2135–2155 (2016).
  • Ha HA, Chiang JH, Tsai FJ et al. Novel quinazolinone MJ-33 induces AKT/mTOR-mediated autophagy-associated apoptosis in 5FU-resistant colorectal cancer cells. Oncol. Rep. 45(2), 680–692 (2021).
  • Hour M-J, Tsai S-C, Wu H-C et al. Antitumor effects of the novel quinazolinone MJ-33: inhibition of metastasis through the MAPK, AKT, NF-κB and AP-1 signaling pathways in DU145 human prostate cancer cells. Int. J. Oncol. 41(4), 1513–1519 (2012).
  • Cubedo E, Cordeu L, Bandres E et al. New symmetrical quinazoline derivatives selectively induce apoptosis in human cancer cells. Cancer Biol. Ther. 5(7), 850–859 (2006).
  • Panja S. Anti-cancer therapeutic potential of quinazoline based small molecules via global upregulation of miRNAs. Chem. Comm. 50(35), 4639–4642 (2014).
  • Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl Acad. Sci. USA 104(39), 15472–15477 (2007).
  • Luo H-J, Si D-J, Sun X-J et al. Structure-based discovery of novel α-aminoketone derivatives as dual p53-MDM2/MDMX inhibitors for the treatment of cancer. Eur. J. Med. Chem. 252, 115282 (2023).
  • Nivedha AK, Tautermann CS, Bhattacharya S et al. Identifying functional hotspot residues for biased ligand design in G-protein-coupled receptors. Mol. Pharmacol. 93(4), 288–296 (2018).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.